Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.66 USD | +2.31% | -22.45% | +168.01% |
Apr. 18 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
Mar. 06 | Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia | CI |
Evolution of the average Target Price on Rezolute, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Rezolute, Inc.
JonesTrading Institutional Services | |
JMP Securities | |
Cantor Fitzgerald | |
Canaccord Genuity | |
HC Wainwright | |
Jefferies & Co. | |
Oppenheimer | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- RZLT Stock
- Consensus Rezolute, Inc.